Host Metabolic Reprogramming During Plasmodium Infection: Implications for Biomarker Discovery and Therapeutics

Zakaria Ali

Department of Pharmacy Kampala International University Uganda

Email:ali.zakaria@studwc.kiu.ac.ug

ABSTRACT

Plasmodium infection triggered profound alterations in host metabolic pathways affecting glucose metabolism, lipid homeostasis, amino acid catabolism, and mitochondrial function across multiple organ systems. These metabolic perturbations represented adaptive host responses aimed at limiting parasite replication and survival, while simultaneously reflecting pathological processes that contributed to disease severity and complications. Understanding the intricate interplay between parasite-induced metabolic reprogramming and clinical outcomes offered opportunities for identifying novel biomarkers and therapeutic targets. This review examined the mechanisms of host metabolic reprogramming during Plasmodium infection and evaluated the translational potential of metabolic signatures for biomarker discovery and development of host-directed therapies. A comprehensive analysis of metabolomic studies, mechanistic investigations, and translational research examining host metabolic responses to malaria across experimental models and human populations was conducted. Plasmodium infection induced glycolytic reprogramming, impaired oxidative phosphorylation, altered lipid metabolism, accelerated amino acid catabolism, and systemic inflammation-driven metabolic dysfunction. Distinct metabolic signatures correlated with disease severity, treatment response, and clinical outcomes, offering potential diagnostic and prognostic utility. Host-directed therapeutic strategies targeting metabolic pathways showed promise in preclinical models but required careful validation to avoid compromising protective immunity. Host metabolic reprogramming represented a critical determinant of malaria pathogenesis and clinical outcome, with emerging applications in precision diagnostics and innovative therapeutic interventions that complement conventional antimalarial drugs.

Keywords: Metabolic reprogramming, Plasmodium infection, Metabolomics, Biomarker discovery, Host-directed therapy.

CITE AS: Zakaria Ali (2026). Host Metabolic Reprogramming During Plasmodium Infection: Implications for Biomarker Discovery and Therapeutics. RESEARCH INVENTION JOURNAL OF BIOLOGICAL AND APPLIED SCIENCES 6(1):94-101. https://doi.org/10.59298/RIJBAS/2026/6194101